Literature DB >> 7475780

FDA advised to license three anti-HIV agents.

H Nelson.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7475780     DOI： 10.1016/s0140-6736(95)92367-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  1 in total

Review 1.  Development of resistance and perspectives for future therapies against hepatitis B infections: lessons to be learned from HIV.

Authors:  K Deres; H Rübsamen-Waigmann
Journal:  Infection       Date:  1999       Impact factor: 3.553
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.